racemetirosine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gustafsson, E | 1 |
| Andsberg, G | 1 |
| Darsalia, V | 1 |
| Mohapel, P | 1 |
| Mandel, RJ | 1 |
| Kirik, D | 1 |
| Lindvall, O | 1 |
| Kokaia, Z | 1 |
1 other study available for racemetirosine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following stroke.
Topics: alpha-Methyltyrosine; Analysis of Variance; Animals; Behavior, Animal; Brain-Derived Neurotrophic Fa | 2003 |